KingMed Diagnostics, headquartered in Guangzhou, China, is a leading medical diagnostics service provider. Founded in 2003, the company started as a pathology laboratory and has since expanded its operations to include a wide range of diagnostic services. KingMed Diagnostics offers a comprehensive suite of products and services, including clinical laboratory testing, pathology services, genetic testing, and medical imaging.

With a focus on precision medicine, the company aims to provide accurate and timely diagnostics to help healthcare professionals make informed treatment decisions. Operating on a global scale, KingMed Diagnostics has established several noteworthy subsidiaries, joint ventures, and partnerships. One significant partnership is its collaboration with Quest Diagnostics, a prominent American diagnostic testing company.

This joint venture, known as KingMed Quest Diagnostics (Beijing) Co., Ltd., leverages the resources and expertise of both companies to expand their reach in the Chinese market. In terms of market position, KingMed Diagnostics is a key player in the Chinese diagnostic market and has gained recognition worldwide. It has a strong presence in China, with over 200 laboratories and more than 950 collection centers across the country.

The company serves a broad range of customers, including hospitals, clinics, and pharmaceutical companies. Over the years, KingMed Diagnostics has achieved numerous milestones and made strategic changes to fuel its growth. In 2015, the company received the Frost & Sullivan China Diagnostics Service Provider of the Year award for its outstanding contributions to the field of diagnostics.

Moreover, KingMed Diagnostics has continually expanded its test menu, offering new and innovative diagnostic tests to meet the evolving needs of the healthcare industry. As of the latest information available, KingMed Diagnostics continues to grow and innovate. However, specific updates or key information beyond this overview are not readily available